Login / Signup

No drug holidays in BRAF V600E glioma patients: An argument for dose reduction of targeted therapies.

Danielle A BazerAnna KolchinskiNancy A O BushJennifer L ClarkeStephen J BagleyKarisa C Schreck
Published in: Neuro-oncology practice (2024)
Clinical and radiographic progression may occur rapidly upon holding BRAF-targeted therapy, warranting judicious dose reductions and minimization of drug holidays.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • metastatic colorectal cancer
  • emergency department
  • adverse drug
  • drug induced
  • wild type